Literature DB >> 9218586

Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis.

J Sibilia1, K Benlagha, P Vanhille, P Ronco, J C Brouet, X Mariette.   

Abstract

We determined the structure of five IgM autoAbs to proteinase-3 (PR3). These Abs are highly specific for Wegener's granulomatosis (WG) and may be involved in the pathogenesis of vasculitis in WG. Five clonal lymphoblastoid cell lines secreting Abs to PR3 were derived from four patients' B cells. From 3 to 5% of supernatants from wells contained detectable anti-PR3 Abs, indicating that anti-neutrophil cytoplasmic Ab specificity represents a sizable part of the IgM B cell repertoire in patients with WG. Mu heavy chains of WG1, WG4-1, and WG4-2 clones belonged to the VH3 subgroup. WG4-1 and WG4-2 heavy chains were identical, indicating an oligoclonal expansion of autoreactive B cells in this patient. WG4-1 (and WG4-2) used the VH3-23 V(H) gene, the product of which was shown to directly bind PR3. Heavy chains of WG2 and WG3 derived from VH4-59 and VH1-2 genes, respectively. Comparison with germline sequences showed that three of the five V(H) genes from clonal lines were somatically mutated with a R:S ratio in complementarity-determining regions of 3:0, 5:1, and 5:1, respectively. Three kappa light chains derived from the Vkappa4 gene, and one derived from a Vkappa1 gene. In these four Vkappa genes, there were overall R:S ratios of mutation of 8:1 and 0:7 in complementarity-determining regions and framework regions, respectively. These data suggest that the production of these autoantibodies, which are increasingly important in the diagnosis and management of WG, are influenced by an Ag-driven process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218586

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis.

Authors:  E Peen; C Malone; C Myers; R C Williams; A B Peck; E Csernok; W L Gross; R Staud
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions.

Authors:  J Voswinkel; A Mueller; J A Kraemer; P Lamprecht; K Herlyn; K Holl-Ulrich; A C Feller; S Pitann; A Gause; W L Gross
Journal:  Ann Rheum Dis       Date:  2005-11-16       Impact factor: 19.103

3.  Identification of two new alleles, IGHV3-23*04 and IGHJ6*04, and the complete sequence of the IGHV3-h pseudogene in the human immunoglobulin locus and their prevalences in Danish Caucasians.

Authors:  Line Ohm-Laursen; Stine Rosenkilde Larsen; Torben Barington
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

4.  [B lymphocyte differentiation in granulomatous tissues of the lung and the nasal mucosa in Wegener's granulomatosis: origin of anti-neutrophil cytoplasmic antibody formation?].

Authors:  J A Krämer; A Müller; K Herlyn; S Pitann; P Lamprecht; K Holl-Ulrich; A C Feller; W L Gross; A Gause; J Voswinkel
Journal:  Z Rheumatol       Date:  2007-09       Impact factor: 1.372

Review 5.  What you should know about PR3-ANCA. Structural aspects of antibodies to proteinase 3 (PR3).

Authors:  E Peen; R C Williams
Journal:  Arthritis Res       Date:  2000-06-12

Review 6.  Staphylococcus aureus and Wegener's granulomatosis.

Authors:  Eliane R Popa; Coen A Stegeman; Cees G M Kallenberg; Jan Willem Cohen Tervaert
Journal:  Arthritis Res       Date:  2001-10-26

7.  Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis.

Authors:  Alvise Berti; Sophie Hillion; Amber M Hummel; Young Min Son; Nedra Chriti; Tobias Peikert; Eva M Carmona; Wayel H Abdulahad; Peter Heeringa; Kristina M Harris; E William St Clair; Paul Brunetta; Fernando C Fervenza; Carol A Langford; Cees Gm Kallenberg; Peter A Merkel; Paul A Monach; Philip Seo; Robert F Spiera; John H Stone; Guido Grandi; Jie Sun; Jacques-Olivier Pers; Ulrich Specks; Divi Cornec
Journal:  JCI Insight       Date:  2021-11-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.